Course Objectives

During the course, the participants will review a total of 200 cases of benign and malignant cutaneous tumors including 50 cases each of melanocytic, vascular, adnexal and lymphoproliferative neoplasms, respectively. Several common diagnostic problems concerning variants of melanoma and melanocytic nevi, high- and low-grade cutaneous vascular tumors and their simulators, cutaneous follicular, apocrine, eccrine and sebaceous neoplasms and cutaneous lymphomas and pseudolymphomas are included.
On each day, at least 10 cases of each diagnostic group will be extensively discussed by an interactive approach. Particular attention will be paid to the diagnostic criteria with systematic analysis of diffrential diagnoses, as well as value and limitations of immunohistochemistry and molecular genetic tools. A comprehensive review and update of relevant literature will be provided. The discussion of the most interesting cases will be integrated into a more general diagnostic approach to these problematic cutaneous neoplasms.

Participants

This intensive course is designed for practicing pathologists as well as pathologists in training.
Attendance is limited to 100 participants.

Course Director

Lorenzo Cerroni, MD
Associate Professor of Dermatology, Department of Dermatology,
Medical University of Graz, Austria
Director, Research Unit of Dermatopathology,
Medical University of Graz, Austria

Guest Faculty

Luis Requena, MD
Professor of Dermatology and Chairman, Department of Dermatology,
Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain

London Dermatopathology Symposium is an international symposium dedicated to high quality teaching in the UK and abroad. With over 30 leading dermatopathologists from around the world as speakers, the 2017 symposium is set to become one of the best international symposia on dermatopathology.

This symposium has been leaving its spot on international dermatopathology teaching with five successful annual symposia. Last year the symposium attracted more than 120 delegates from over 26 countries.  With an impressive lineup of speakers, the 2017 symposium is set to become even bigger and we expect to attract more delegates than ever. The symposium includes the popular self-assessment session and the practical multiheader sessions. Leading speakers will be offering short courses on important areas. Check out this year’s programme to find out more about what is on offer.

EVENT PRICE LIST & Registration

London Dermatopathology Symposium is very popular around the world with dermatopathologists from over 26 countries attending the 2016 symposium. This is because of the impressive speaker lineup. Register early and avail the early bird rate to save £40 on registration fee. You can also register only the second or the third day for a lower price. Take a look at the price table below.

OBJECTIVE

The goal of the Course is to cover the most difficult diagnostic problems encountered by practicing pathologists in the areas of cutaneous and ocular melanoma. The approach of the Course will be practical based on the extensive experience of the Directors of the Course and other invited speakers. The Course will consist of a series of didactic lectures and interactive sessions during the two-day period. Digitized images of specific cases will be available for review in advance of the Course and will be discussed in the interactive sessions of the Course.

SELECTED TOPICS

• General approach to the difficult melanocytic lesion
• Dysplastic and other atypical cutaneous melanocytic nevi
• Spitzoid melanocytic tumors
• Blue nevi and atypical variants
• Nevoid, desmoplastic, blue nevus-like, conventional cutaneous, pediatric, acral, mucosal, conjunctival, uveal melanomas
• Primary acquired melanosis
• Melanocytic lesions of the nail apparatus
• The latest AJCC guidelines (8th Edition) for cutaneous and ocular melanoma staging
• Practical immunohistochemistry and molecular analysis of melanocytic lesions Immune checkpoint pathways
• The reporting of melanoma and prognostic factors
• What the clinician expects from the pathologist